Bruno P. Granwehr, MD, MS, FACP, FIDSA
Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Professor, Department of Infectious Diseases, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Infectious Diseases, Baylor College of Medicine, Houston, TX
Education & Training
Degree-Granting Education
| 2005 | The University of Texas Medical Branch, Galveston, TX, USA, MS, Clinical Investigation |
| 1999 | University of Iowa Carver College of Medicine, Iowa City, IA, USA, MD, Medicine |
| 1994 | University of Iowa College of Liberal Arts, Iowa City, IA, USA, BS, Microbiology |
Postgraduate Training
| 2002-2005 | Clinical Fellowship, Infectious Diseases (Internal Medicine), The University of Texas Medical Branch, Galveston, TX |
| 1999-2002 | Clinical Residency, Internal Medicine, University of Rochester-Strong Memorial Hospital, Rochester, NY |
Board Certifications
| 2014 | American Board of Medical Quality, Certified in Medical Quality |
| 2005 | American Board of Internal Medicine, Diplomat in Infectious Diseases |
| 2002 | American Board of Internal Medicine, Diplomat in Internal Medicine |
Experience & Service
Administrative Appointments/Responsibilities
Clinical Director, ICU/Hospitalist ID Consult Service, University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2019
Director of Academic Training Programs, Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2017
Site Director and Associate Director, MD Anderson-Baylor College of Medicine-Infectious Diseases Fellowship Program, University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2017
Site Director, MD Anderson Cancer Center, University of Texas-Houston Medical School Infectious Diseases Fellowship, University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2016
Other Appointments/Responsibilities
Facilitator-REDE to Communicate® Skills Program, UT MD Anderson Cancer Center, Houston, TX, 2022 - Present
Team Member-Pre-Discharge Subgroup Co-Team Lead, Inpatient Care Coordination Team, Houston, TX, 2019 - Present
Member, MD Anderson ECMM Mycology Center, Houston, TX, 2018 - Present
Institutional Committee Activities
Vice Chair, Acute and Critical Care Subcommittee, 2022 - Present
Member, Utilization Review Committee, 2022 - Present
Member, Professional Education Committee, 2021 - Present
Member, Transparency Governance Council, 2019 - Present
Member, Professional Liability Committee, 2018 - Present
Member, Acute and Critical Care Subcommittee, 2017 - 2022
Member, Psychosocial, Behavioral and Health Services Research Committee, 2016 - 2019
Member, Infection Control Committee, UT MD Anderson, 2007 - 2016
Honors & Awards
| 2019 | Multiyear Appointment Award, University of Texas MD Anderson Cancer Center |
| 2018 | Baylor ID Fellows MD Anderson Faculty Teacher of the Year |
| 2011 | Fellow, American College of Physicians |
| 2002 | T32 NIH-NIAID-Sponsored Postdoctoral Fellowship in Emerging and Reemerging Infectious Diseases, UTMB-Galveston |
| 1999 | Healthcare Foundation of New Jersey Humanism in Medicine Award, University of Iowa College of Medicine |
Selected Publications
Peer-Reviewed Articles
- Rice TW, Brock PA, Gonzalez C, Merriman KW, Shelal Z, Bazerbashi H, Granwehr BP. Routine HIV Screening in Cancer Patients in the Emergency Department. Acute Med 17(2):91-95, 2018. PMID: 29882559.
- Angelidakis G, Hwang JP, Dandachi D, Economides MP, Hosry J, Granwehr BP, Torres HA. Universal screening for hepatitis C: A needed approach in patients with haematologic malignancies. J Viral Hepat 25(9):1102-1104, 2018. e-Pub 2018. PMID: 29660201.
- Hwang JP, Lok AS, Fisch MJ, Cantor SB, Barbo A, Lin HY, Foreman JT, Vierling JM, Torres HA, Granwehr BP, Miller E, Eng C, Simon GR, Ahmed S, Ferrajoli A, Romaguera J, Suarez-Almazor ME. Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study. J Clin Oncol 36(10):JCO2017756387, 2018. e-Pub 2018. PMID: 29447061.
- Tverdek FP, Heo ST, Aitken SL, Granwehr B, Kontoyiannis DP. Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses. Antimicrob Agents Chemother 61(8), 2017. e-Pub 2017. PMID: 28507111.
- Ariza-Heredia EJ, Granwehr BP, Viola GM, Bhatti M, Kelley JM, Kochenderfer J, Hosing C. False-positive HIV nucleic acid amplification testing during CAR T-cell therapy. Diagn Microbiol Infect Dis 88(4):305-307, 2017. e-Pub 2017. PMID: 28610774.
- Chaftari AM, Hachem R, Szvalb A, Taremi M, Granwehr B, Viola GM, Amin S, Assaf A, Numan Y, Shah P, Gasitashvili K, Natividad E, Jiang Y, Slack R, Reitzel R, Rosenblatt J, Mouhayar E, Raad I. A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients. Antimicrob Agents Chemother 61(7), 2017. e-Pub 2017. PMID: 28416559.
- Economides MP, Mahale P, Turturro F, Hosry J, Samaniego F, Granwehr BP, Torres HA. Development of non-Hodgkin lymphoma as a second primary cancer in hepatitis C virus-infected patients with a different primary malignancy. Leuk Lymphoma 27(2):1-4, 2017. e-Pub 2016. PMID: 27348218.
- Hosry J, Mahale P, Turturro F, Miranda RN, Economides MP, Granwehr BP, Torres HA. Antiviral therapy improves survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma. Int J Cancer 139(11):2519-28, 2016. e-Pub 2016. PMID: 27501007.
- Torres HA, Roach LR, Mahale P, Economides MP, Blechacz B, Miller E, Borchardt R, Rashid A, Oo TH, Shukla B, Farida M, Ericsson CD, Granwehr BP, Raad II. Transdisciplinary approach to managing Hepatitis C virus infection in patients at tertiary care cancer center. J Natl Compr Canc Netw 14(9):1185-8, 2016. PMID: 27587628.
- Chaftari AM, Hachem R, Jordan M, Garoge K, Al Hamal Z, El Zakhem A, Viola GM, Granwehr B, Mulanovich V, Gagel A, Reitzel R, Yousif A, Jiang Y, Raad I. Case-control study of Telavancin as an alternative treatment for gram-positive bloodstream infections in patients with cancer. Antimicrob Agents Chemother 19(60):239-44, 2016. e-Pub 2015. PMID: 26482312.
- Hwang JP, Granwehr BP, Torres HA, Suarez-Almazor ME, Giordano TP, Barbo AG, Lin HY, Fisch MJ, Chiao EY. HIV testing in patients with cancer at the initiation of therapy at a large US comprehensive cancer center. J Oncol Pract 11(5):384-90, 2015. e-Pub 2015. PMID: 26243649.
- Torres HA, Rallapalli V, Saxena A, Granwehr BP, Viola GM, Ariza-Heredia E, Adachi JA, Chemaly RF, Marfatia R, Jiang Y, Mahale P, Kyvernitakis A, Fanale MA, Mulanovich V. Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Clin Microbiol Infect 20(10):672-9, 2014. e-Pub 2014. PMID: 24529214.
- Granwehr BP, Kontoyiannis DP. The Impact of Infectious Diseases Consultation of Oncology Practice. Curr Opin Oncol 4(4):353-9, 2013. e-Pub 2013. PMID: 23736876.
- Chemaly RF, Vigil KJ, Saad M, Vilar-Compte D, Cornejo-Juarez P, Perez-Jimenez C, Mubarak S, Salhab M, Jiang Y, Granwehr B, Adachi JA, Raad II. A multicenter study of pandemic influenza a (H1N1) infection in patients with solid tumors in 3 countries: Early therapy improves outcomes. Cancer 118(18):4627-33, 2012. e-Pub 2012. PMID: 22359314.
- Cairo J, Hachem R, Rangaraj G, Granwehr B, Raad I. Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients. Clin Microbiol Infect 17(11):1711-16, 2011. e-Pub 2011. PMID: 21595787.
- Al Wohoush I, Cairo J, Rangaraj G, Granwehr B, Hachem R, Raad I. Comparing quantitative culture of a blood sample obtained through the catheter with differential time to positivity in establishing a diagnosis of catheter-related bloodstream infection. Infect Control Hosp Epidemiol 31(10):1089-91, 2010. PMID: 20807036.
- Rangaraj G, Granwehr BP, Jiang Y, Hachem R, Raad I. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer 116(4):967-73, 2010. PMID: 20052728.
- Granwehr BP, Li L, Davis CT, Beasley DW, Barrett AD. Characterization of a West Nile Virus Isolate from a Human on the Gulf Coast of Texas. J Clin Microbiol 42(11):5375-5377, 2004. PMID: 15528747.
- Granwehr BP, Lillibridge KM, Higgs S, Mason PW, Aronson JF, Campbell GA, Barrett AD. West Nile Virus: Where Are We Now?. Lancet Infect Dis 4(9):547-56, 2004. PMID: 15336221.
- Solomon T, Fisher AF, Beasley DW, Mandava P, Granwehr BP, Langsjoen H, Travassos Da Rosa AP, Barrett AD, Tesh RB. Natural and Nosocomial Infection in a Patient with West Nile Encephalitis and Extrapyramidal Movement Disorders. Clin Infect Dis 36(11):e140-145, 2003. e-Pub 2003. PMID: 12766856.
Invited Articles
- Granwehr B. ACP Journal Club. One or two 7.5-microg doses of MF59-adjuvanted influenza A (H1N1) 2009 vaccine was immunogenic in adults within 21 days. Ann Intern Med 152(2):JC1-8, JC1-9, 2010. PMID: 20083823.
- Granwehr B. ACP Journal Club. A 15-microg dose of unadjuvanted influenza A (H1N1) 2009 vaccine was immunogenic in healthy adults within 21 days. Ann Intern Med 152(2):JC1-9, JC1-8, 2010. PMID: 20083824.
- Granwehr BP. ACP Journal Club. Quadrivalent HPV vaccine reduced risk for HPV infection and related disease in women 24 to 45 years of age. Ann Intern Med 151(8):JC4-12, 2009. PMID: 19841449.
- Granwehr BP. Influenza immunization during pregnancy reduced influenza in infants and respiratory illness in mothers. Evid Based Med 14(2):55, 2009. PMID: 19332611.
- Granwehr BP. ACP Journal Club. Influenza immunization during pregnancy reduced influenza in infants and respiratory illness in mothers. Ann Intern Med 150(4):JC2-5, 2009. PMID: 19238603.
- Granwehr B. Inactivated influenza vaccine prevented influenza in healthy adults. ACP J Club 146(3):60, 2007. PMID: 17474669.
Book Chapters
- Granwehr BP, Chemaly RF, Kontoyiannis DP. Fungal and Viral Infections in Cancer Patients. In: The MD Anderson Manual of Medical Oncology. 3rd. McGraw-Hill Companies, 1035-1055, 2016.
- Safdar A, Granwehr BP, Harold SA, Dupont HL. Chapter 16: Neutropenic Enterocolitis and Clostridium difficile Infections. In: Management of Infections in Cancer Patients. Humana Press, 181-188, 2011.
- Watts DM, Granwehr BP, Shope RE, Solomon TS, Tesh RB. Japanese Encephalitis and West Nile and Other Flavivirus Infections. In: Tropical Infectious Diseases. 2nd. Elsevier Publishers, 823-830, 2005.
Grant & Contract Support
| Title: | T32 Emerging and Re-emerging Infectious Diseases, Study of Molecular Determinants of Virulence of West Nile Virus Infection, WHO Collaborating Center for Tropical Diseases, Sealy Center for Vaccine Development |
| Funding Source: | NIH/NIAID |
| Role: | Postdoctoral Fellow |
Patient Reviews
CV information above last modified December 05, 2023